Zafgen Obtains $21,000,000 New Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=47ca6874-0599-4fde-901b-d5b5745cfa29&Preview=1 -
Date
12/4/2012 -
Company Name
Zafgen -
Mailing Address
1 Cambridge Center Cambridge, MA 02142 -
Company Description
The company is developing novel therapeutics for the treatment of obesity. -
Website
http://www.zafgen.com -
Transaction Type
Venture Equity -
Transaction Amount
$21,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds from the financing will be used to support the continued development of beloranib, the obesity therapeutic that is currently in phase 2a clinical development. -
M&A Terms
-
Venture Investor
Alta Partners -
Venture Investor
Atlas Venture -
Venture Investor
Third Rock Ventures
